Encoded Therapeutics
CA - South SFBiotechnology
Focus: Encoded Therapeutics is a gene therapy-focused biotech company headquartered in South San Francisco, operating as a public company since 2000 with a lean pipeline concentrated on Dravet Syndrome.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
4
Should You Work at Encoded Therapeutics?
AI assessmentAttractive for gene therapy specialists willing to accept early-stage development risk in exchange for focused, science-forward career growth.
Why Work Here
- Focused gene therapy pipeline with ETX101 in Phase 1/2 for high-unmet-need Dravet Syndrome, offering deep scientific specialization
- Public company status provides equity upside and career visibility compared to private stage biotech
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
4 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GABA Blood Level
Dravet SyndromeClinical Trials (1)
NCT05651204GABA Biomarkers in Dravet Syndrome
N/AHelp build intelligence for Encoded Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.